344 related articles for article (PubMed ID: 33806312)
1. The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials.
Hervieu C; Christou N; Battu S; Mathonnet M
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33806312
[TBL] [Abstract][Full Text] [Related]
2. MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine.
Guo M; Luo B; Pan M; Li M; Zhao F; Dou J
Int Immunopharmacol; 2020 Aug; 85():106631. PubMed ID: 32470879
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria in colorectal cancer stem cells - a target in drug resistance.
Rainho MA; Siqueira PB; de Amorim ÍSS; Mencalha AL; Thole AA
Cancer Drug Resist; 2023; 6(2):273-283. PubMed ID: 37457136
[TBL] [Abstract][Full Text] [Related]
4. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment.
Jahanafrooz Z; Mosafer J; Akbari M; Hashemzaei M; Mokhtarzadeh A; Baradaran B
J Cell Physiol; 2020 May; 235(5):4153-4166. PubMed ID: 31647128
[TBL] [Abstract][Full Text] [Related]
5. The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy.
Guo M; You C; Dong W; Luo B; Wu Y; Chen Y; Li J; Pan M; Li M; Zhao F; Dou J
Biomed Pharmacother; 2020 Dec; 132():110804. PubMed ID: 33017767
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer.
Guo M; Luo B; Pan M; Li M; Xu H; Zhao F; Dou J
Int Immunopharmacol; 2020 Nov; 88():106850. PubMed ID: 32777675
[TBL] [Abstract][Full Text] [Related]
7. Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells.
Liu L; Liu Y; Xia Y; Wang G; Zhang X; Zhang H; Xu Y; Yuan Y; Liu S; Wang Y
J Cancer; 2021; 12(22):6629-6639. PubMed ID: 34659553
[TBL] [Abstract][Full Text] [Related]
8. USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide.
Zhang S; Ju X; Yang Q; Zhu Y; Fan D; Su G; Kong L; Li Y
Biochem Biophys Res Commun; 2021 Jul; 562():21-28. PubMed ID: 34030041
[TBL] [Abstract][Full Text] [Related]
9. Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome.
Angius A; Scanu AM; Arru C; Muroni MR; Rallo V; Deiana G; Ninniri MC; Carru C; Porcu A; Pira G; Uva P; Cossu-Rocca P; De Miglio MR
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562604
[TBL] [Abstract][Full Text] [Related]
10. Targeting stemness of cancer stem cells to fight colorectal cancers.
Du L; Cheng Q; Zheng H; Liu J; Liu L; Chen Q
Semin Cancer Biol; 2022 Jul; 82():150-161. PubMed ID: 33631296
[TBL] [Abstract][Full Text] [Related]
11. Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis.
Kantara C; O'Connell MR; Luthra G; Gajjar A; Sarkar S; Ullrich RL; Singh P
Lab Invest; 2015 Jan; 95(1):100-12. PubMed ID: 25347154
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic tumor cell line-based vaccines: A good alternative to autologous and cancer stem cell vaccines in colorectal cancer.
Rafieenia F; Nikkhah E; Nourmohammadi F; Hosseini S; Abdollahi A; Sharifi N; Aliakbarian M; Forghani Fard MM; Gholamin M; Abbaszadegan MR
Iran J Basic Med Sci; 2021 Sep; 24(9):1231-1239. PubMed ID: 35083010
[TBL] [Abstract][Full Text] [Related]
14. Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer.
Lucchetti D; Luongo F; Colella F; Gurreri E; Artemi G; Desiderio C; Serra S; Giuliante F; De Maria R; Sgambato A; Vitali A; Fiori ME
Biomed Pharmacother; 2023 Jun; 162():114679. PubMed ID: 37068332
[TBL] [Abstract][Full Text] [Related]
15. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
Zheng X; Yu C; Xu M
Front Oncol; 2021; 11():678333. PubMed ID: 34262865
[TBL] [Abstract][Full Text] [Related]
16. Advances and perspectives of colorectal cancer stem cell vaccine.
Guo M; Dou J
Biomed Pharmacother; 2015 Dec; 76():107-20. PubMed ID: 26653557
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer stem cells: Potential target for the treatment of colorectal cancer.
Gupta R; Bhatt LK; Johnston TP; Prabhavalkar KS
Cancer Biol Ther; 2019; 20(8):1068-1082. PubMed ID: 31050577
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling.
Leung WH; Shih JW; Chen JS; Mokgautsi N; Wei PL; Huang YJ
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203586
[TBL] [Abstract][Full Text] [Related]
19. The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission.
Kopenhaver J; Crutcher M; Waldman SA; Snook AE
Expert Opin Biol Ther; 2021 Oct; 21(10):1335-1345. PubMed ID: 33977849
[No Abstract] [Full Text] [Related]
20. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
Guo M; You C; Dou J
Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
